Applications of AI in healthcare, including medical diagnostics, drug discovery, patient care solutions, and biotechnology research.
Ingenix has raised €13 million in seed extension funding led by Sofinnova Partners to scale its Biological Reasoning Engine and launch the Qualified Access Program for pharma and biotech partners.
Adaptive Innovations has raised $50 million in Series A funding led by Felicis, with participation from Bain Capital Ventures and others. The funding will support the expansion of its AI healthcare platform and clinical workforce across new states.
The American Diabetes Association’s Innovation Fund has made a strategic investment in UpDoc to advance its clinical AI platform for chronic disease management and prevention.
WeInfuse has announced a partnership with Trial IQ Technologies to integrate AI tools that help infusion providers launch and manage clinical trial programs, expanding access to research within community care settings.
Mayo Clinic and Microsoft have announced a collaboration to build a frontier AI model designed specifically for healthcare, combining Mayo's clinical expertise with Microsoft's AI and cloud capabilities.
Pathwork has introduced an AI platform that gives life insurance brokers instant access to prescription and medical claims data, allowing faster and more informed underwriting decisions.
Acclinate and HCN Global have announced a partnership integrating their health engagement networks to improve clinical trial participation among Hispanic and Latino populations, using Acclinate's e-DICT platform and predictive analytics tools.
Cortechs.ai has announced a collaboration with Microsoft to embed its AI imaging solutions, including NeuroQuant and OnQ Prostate, into Microsoft's PowerScribe One reporting system. The integration aims to deliver quantitative imaging insights directly within radiology workflows.
RSC Bay Area has become the first fertility clinic in the United States to use Alife Health’s FDA-cleared Embryo Predict AI tool in routine IVF care, providing patients with AI-assisted embryo selection.
Mount Sinai Health System will implement Clarium’s AI-powered computer vision technology across its hospitals to automate surgical supply tracking and reduce waste, according to a press release.
Converge Bio has secured a $2.5 million grant from the Gates Foundation to expand its AI gene discovery platform from pharmaceuticals to crop genomics, aiming to improve agricultural resilience and accelerate crop breeding cycles.
Tissue Dynamics and Galmed Pharmaceuticals have discovered a previously unknown metabolic mechanism involved in cardiac fibrosis using human cardiac organoid models, showing that a combination of Aramchol Meglumine and a PPARα agonist can significantly reduce fibrotic burden.
The U.S. Food and Drug Administration has cleared Clarius Mobile Health's Ejection Fraction AI tool, which automates cardiac ultrasound analysis to measure heart pumping efficiency in real time within the Clarius App.
Genomics has launched Mystra AI, a conversational platform that leverages the world's largest human genetics database to support drug target discovery and validation, offering researchers access to genetic insights through plain language queries.
Compal Electronics showcased its POLYMEDX Physical AI platform at COMPUTEX 2026, highlighting expanded collaboration with NVIDIA to accelerate smart hospital operations through robotics, AI orchestration, and digital twin technologies.
Kedrion Biopharma and InstaLILY will co-host the Rare Connections: Healthcare AI Innovation Summit on June 3 during NY Tech Week, bringing together leaders from pharma, technology, and research to discuss the practical use of AI in healthcare.
AssureCare has launched NutraVance, an AI-enabled platform that integrates nutrition management directly into healthcare workflows, supporting Food as Medicine programs with tools for assessment, care planning, engagement, and reimbursement.
Conscientia Health has launched a clinician supervised AI platform designed to support mental health providers with tools for patient matching, clinical decision support, and predictive insights.
3billion has introduced 3B-NEO, a genomic newborn screening service analyzing 595 genes linked to actionable childhood disorders, with results delivered in about two weeks.
GRAIL presented full results from the NHS-Galleri trial at the 2026 ASCO Annual Meeting, showing a reduction in Stage IV cancer diagnoses and increased detection rates when the Galleri test was added to standard screening.
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
